Yao Yi, Zhang Yonggang, Liao Xiaoyang, Yang Rong, Lei Yi, Luo Jianzhao
International Medical Center, Ward of General Practice and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
Department of Periodical Press and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
Front Aging Neurosci. 2021 Feb 4;12:618819. doi: 10.3389/fnagi.2020.618819. eCollection 2020.
Stroke is the leading cause of global mortality and disability. Cerebral edema and intracranial hypertension are common complications of cerebral infarction and the major causes of mortality. The formation of cerebral edema includes three stages (cytotoxic edema, ionic edema, and vasogenic edema), which involve multiple proteins and ion channels. A range of therapeutic agents that successfully target cerebral edema have been developed in animal studies, some of which have been assessed in clinical trials. Herein, we review the mechanisms of cerebral edema and the research progress of anti-edema therapies for use after ischemic stroke.
中风是全球死亡和残疾的主要原因。脑水肿和颅内高压是脑梗死的常见并发症,也是死亡的主要原因。脑水肿的形成包括三个阶段(细胞毒性水肿、离子性水肿和血管源性水肿),涉及多种蛋白质和离子通道。在动物研究中已经开发出一系列成功靶向脑水肿的治疗药物,其中一些已在临床试验中进行了评估。在此,我们综述脑水肿的机制以及缺血性中风后抗水肿治疗的研究进展。